New GABA-modulating 1,2,4-oxadiazole derivatives and their anticonvulsant activity
Authors:
- Hans-Joachim LankauHLHans-Joachim Lankau
- Klaus UnverferthKUKlaus Unverferth
- Christian GrunwaldCGChristian Grunwald
- Helge HartenhauerHHHelge Hartenhauer
- Kristina HeineckeKHKristina Heinecke
- Katrin BernösterKBKatrin Bernöster
- Rita DostRDRita Dost
- Ute EgerlandUEUte Egerland
- Chris RundfeldtCRChris Rundfeldt
- 1 June 2007
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 42 (6) , 873-879
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Refractory epilepsy: mechanisms and solutionsExpert Review of Neurotherapeutics, 2006
- Activity profile of pregabalin in rodent models of epilepsy and ataxiaEpilepsy Research, 2006
- Molecular targets versus models for new antiepileptic drug discoveryEpilepsy Research, 2006
- Treatment of seizure emergencies: Convulsive and non-convulsive status epilepticusEpilepsy Research, 2006
- Drug Resistance in Epilepsy: Putative Neurobiologic and Clinical MechanismsEpilepsia, 2005
- Drug Treatment of Epilepsy: When Does It Fail and How to Optimize Its Use?CNS Spectrums, 2004
- Early Identification of Refractory EpilepsyNew England Journal of Medicine, 2000
- New Antiepileptic DrugsNew England Journal of Medicine, 1996
- Antiepileptic DrugsNew England Journal of Medicine, 1996
- 1,2,4-Oxadiazoles--IV. Synthesis and Pharmacological Properties of a Series of Substituted Aminoalkyl-1,2,4-oxadiazolesJournal of Medicinal Chemistry, 1961